Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-30 Exercise |
2022-10-03 7:57 pm |
N/A N/A |
Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director |
2,859 | $0 | 65,130 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-03 7:55 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
13,911 | $0 | 4,519,706 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2022-10-03 7:55 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
4,077 | $1.52 | 4,519,706 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-03 7:45 pm |
N/A N/A |
Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director |
2,859 | $0 | 3,076,124 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-03 7:42 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
4,063 | $0 | 60,997 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2022-10-03 7:42 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
1,191 | $1.52 | 60,997 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-03 7:41 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Brown Michael J Director |
2,859 | $0 | 4,503,670 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-03 7:38 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Anderson Raymond Director |
2,859 | $0 | 16,730 (Direct) |
View |
| 2022-06-30 Exercise |
2022-07-01 4:19 pm |
N/A N/A |
Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director |
2,859 | $0 | 3,076,124 (Direct) |
View |
| 2022-06-30 Exercise |
2022-07-01 4:17 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
8,125 | $0 | 62,188 (Direct) |
View |
| 2022-06-30 Tax Withholding |
2022-07-01 4:17 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
2,812 | $2.299 | 62,188 (Direct) |
View |
| 2022-06-30 Exercise |
2022-07-01 4:15 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Brown Michael J Director |
2,859 | $0 | 4,503,670 (Direct) |
View |
| 2022-06-30 Exercise |
2022-07-01 4:14 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Anderson Raymond Director |
2,859 | $0 | 16,730 (Direct) |
View |
| 2022-06-30 Exercise |
2022-07-01 4:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
23,882 | $0 | 4,523,783 (Direct) |
View |
| 2022-06-30 Tax Withholding |
2022-07-01 4:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
6,999 | $2.299 | 4,523,783 (Direct) |
View |
| 2022-06-30 Exercise |
2022-07-01 4:06 pm |
N/A N/A |
Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director |
2,859 | $0 | 65,130 (Direct) |
View |
| 2022-06-30 Exercise |
2022-07-01 4:05 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
8,913 | $0 | 79,977 (Direct) |
View |
| 2022-06-30 Tax Withholding |
2022-07-01 4:05 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
3,083 | $2.299 | 79,977 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-01 5:28 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
3,941 | $0 | 4,530,782 (Direct) |
View |
| 2022-03-31 Tax Withholding |
2022-04-01 5:28 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
1,155 | $2.55 | 4,530,782 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-01 5:28 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Mazar Andrew Paul Chief Scientific Officer |
1,606 | $0 | 4,388,857 (Direct) |
View |
| 2022-03-31 Tax Withholding |
2022-04-01 5:28 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Mazar Andrew Paul Chief Scientific Officer |
471 | $2.55 | 4,388,857 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-01 5:28 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
1,221 | $0 | 83,060 (Direct) |
View |
| 2022-03-31 Tax Withholding |
2022-04-01 5:28 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
500 | $2.55 | 83,060 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-01 5:03 pm |
N/A N/A |
Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director |
2,859 | $0 | 3,076,124 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-01 5:02 pm |
N/A N/A |
Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director |
2,859 | $0 | 65,130 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-01 5:02 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Anderson Raymond Director |
2,859 | $0 | 16,730 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-01 5:02 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Brown Michael J Director |
2,859 | $0 | 4,503,670 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 7:38 pm |
N/A 2032-02-01 |
Monopar Therapeutics | MNPR | Mazar Andrew Paul Chief Scientific Officer |
156,125 | $0 | 179,272 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 7:37 pm |
N/A 2032-02-01 |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
370,540 | $0 | 431,282 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 7:36 pm |
N/A 2032-02-01 |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
142,927 | $0 | 160,040 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 7:35 pm |
N/A 2032-02-01 |
Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director |
26,564 | $0 | 26,564 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 7:34 pm |
N/A 2032-02-01 |
Monopar Therapeutics | MNPR | Brown Michael J Director |
26,564 | $0 | 26,564 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 7:33 pm |
N/A 2032-02-01 |
Monopar Therapeutics | MNPR | Anderson Raymond Director |
26,564 | $0 | 26,564 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 7:30 pm |
N/A 2032-02-01 |
Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director |
26,564 | $0 | 26,564 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 7:29 pm |
N/A 2032-02-01 |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-01-01 Exercise |
2022-01-04 2:49 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Mazar Andrew Paul Chief Scientific Officer |
1,937 | $0 | 4,302,804 (Direct) |
View |
| 2022-01-01 Tax Withholding |
2022-01-04 2:49 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Mazar Andrew Paul Chief Scientific Officer |
671 | $3.21 | 4,302,804 (Direct) |
View |
| 2021-12-31 Exercise |
2022-01-04 2:40 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Mazar Andrew Paul Chief Scientific Officer |
1,606 | $0 | 4,316,937 (Direct) |
View |
| 2021-12-31 Tax Withholding |
2022-01-04 2:40 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Mazar Andrew Paul Chief Scientific Officer |
556 | $3.21 | 4,316,937 (Direct) |
View |
| 2022-01-01 Exercise |
2022-01-04 2:31 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
1,231 | $0 | 7,376 (Direct) |
View |
| 2022-01-01 Tax Withholding |
2022-01-04 2:31 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
505 | $3.21 | 7,376 (Direct) |
View |
| 2021-12-31 Exercise |
2022-01-04 2:27 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
1,221 | $0 | 18,841 (Direct) |
View |
| 2021-12-31 Tax Withholding |
2022-01-04 2:27 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer |
501 | $3.21 | 18,841 (Direct) |
View |
| 2022-01-01 Exercise |
2022-01-04 2:17 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
6,724 | $0 | 4,325,120 (Direct) |
View |
| 2022-01-01 Tax Withholding |
2022-01-04 2:17 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
2,327 | $3.21 | 4,325,120 (Direct) |
View |
| 2021-12-31 Exercise |
2022-01-04 2:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
3,941 | $0 | 4,354,571 (Direct) |
View |
| 2021-12-31 Tax Withholding |
2022-01-04 2:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer |
1,364 | $3.21 | 4,354,571 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 1:47 pm |
N/A 2031-12-31 |
Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-12-31 Exercise |
2022-01-04 1:45 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Anderson Raymond Director |
751 | $0 | 5,294 (Direct) |
View |
| 2021-12-31 Exercise |
2022-01-04 1:36 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Brown Michael J Director |
751 | $0 | 4,492,234 (Direct) |
View |
| 2021-12-31 Exercise |
2022-01-04 1:20 pm |
N/A N/A |
Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director |
751 | $0 | 53,694 (Direct) |
View |
| 2021-12-31 Exercise |
2022-01-04 12:59 pm |
N/A N/A |
Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director |
751 | $0 | 3,064,688 (Direct) |
View |
| 2021-09-30 Exercise |
2021-10-01 7:31 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Mazar Andrew Paul Chief Scientific Officer |
1,606 | $0 | 4,317,493 (Direct) |
View |
| 2021-09-30 Tax Withholding |
2021-10-01 7:31 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Mazar Andrew Paul Chief Scientific Officer |
471 | $4.87 | 4,317,493 (Direct) |
View |